Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...
Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société de biotechnologie de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes...
Consolidated revenue of €3.4m at the end of September 2024 Cash position of €4.1m before receipt of IRIS Pharma’s CIR (€610k) as of September 30, 2024 Live broadcast of the General Meeting on...
Proposed appointment of Jean-Gérard Galvez, Luc Demarre and Caroline DeSurmont as directors Proposed financial delegations necessary for the Company's development Proposed amendments to the...
Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.092 | -7.02290076336 | 1.31 | 1.326 | 1.212 | 36357 | 1.27948132 | DE |
4 | -0.102 | -7.72727272727 | 1.32 | 1.35 | 1.2 | 40447 | 1.29281485 | DE |
12 | -0.1 | -7.58725341426 | 1.318 | 1.5 | 1.128 | 48516 | 1.29490514 | DE |
26 | -0.148 | -10.8345534407 | 1.366 | 1.5 | 1.11 | 43348 | 1.28797111 | DE |
52 | -0.09 | -6.88073394495 | 1.308 | 1.5 | 0.91 | 50131 | 1.22479113 | DE |
156 | -1.332 | -52.2352941176 | 2.55 | 3.57 | 0.91 | 102819 | 1.8349046 | DE |
260 | 0.866 | 246.022727273 | 0.352 | 3.57 | 0.32 | 245609 | 1.41197133 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales